The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
Open accessAbstract
BACKGROUND: The effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis are unclear. Lung cancer findings and mortality rates are reported at the end of screening in the Danish Lung Cancer Screening Trial. METHODS: 4104 men and women, healthy heavy smokers/former smokers were randomised to five annual low-dose CT screenings or no screening. Two experienced chest radiologists read all CT scans and registered the location, size and morphology of nodules. Nodules between 5 and 15 mm without benign characteristics were rescanned after 3 months. Growing nodules (>25% volume increase and/or volume doubling time<400 days) and nodules >15 mm were referred for diagnostic workup. In the control group, lung cancers were diagnosed and treated outside the study by the usual clinical practice. RESULTS: Participation rates were high in both groups (screening: 95.5%; control: 93.0%; p<0.001). Lung cancer detection rate was 0.83% at baseline and mean annual detection rate was 0.67% at incidence rounds (p=0.535). More lung cancers were diagnosed in the screening group (69 vs. 24, p<0.001), and more were low stage (48 vs 21 stage I-IIB non-small cell lung cancer (NSCLC) and limited stage small cell lung cancer (SCLC), p=0.002), whereas frequencies of high-stage lung cancer were the same (21 vs 16 stage IIIA-IV NSCLC and extensive stage SCLC, p=0.509). At the end of screening, 61 patients died in the screening group and 42 in the control group (p=0.059). 15 and 11 died of lung cancer, respectively (p=0.428). CONCLUSION: CT screening for lung cancer brings forward early disease, and at this point no stage shift or reduction in mortality was observed. More lung cancers were diagnosed in the screening group, indicating some degree of overdiagnosis and need for longer follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Mass screening for lung cancer with mobile spiral computed tomography scanner
Sone, S., Takashima, S., Li, F., Yang, Z., Honda, T., Maruyama, Y., Hasegawa, M., Yamanda, T., Kubo, K., Hanamura, K., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08229-9 · Cited by 931
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A. M., van 't Westeinde, S., van der Aalst, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 820
CT Screening for Lung Cancer: Five-year Prospective Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Mandrekar, S. J., Hillman, S. L., Sykes, A.-M., Aughenbaugh, G. L., Bungum, A. O., & Allen, K. L. (2005) · Radiology · doi:10.1148/radiol.2351041662 · Cited by 636
Rethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Pedersen, J. H., Ashraf, H., Dirksen, A., Bach, K., Hansen, H., Toennesen, P., Thorsen, H., Brodersen, J., Skov, B. G., Døssing, M., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a0d98f · Cited by 434
Self-citationInfante, M., Cavuto, S., Lutman, F. R., Brambilla, G., Chiesa, G., Ceresoli, G., Passera, E., Angeli, E., Chiarenza, M., Aranzulla, G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0076oc · Cited by 379
Lopes Pegna, A., Picozzi, G., Mascalchi, M., Maria Carozzi, F., Carrozzi, L., Comin, C., Spinelli, C., Falaschi, F., Grazzini, M., Innocenti, F., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.003 · Cited by 294
The Natural History of Invasive Breast Cancers Detected by Screening Mammography
Zahl, P.-H., Mæhlen, J., & Welch, H. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2311 · Cited by 285
5-Year Lung Cancer Screening Experience
Lindell, R. M., Hartman, T. E., Swensen, S. J., Jett, J. R., Midthun, D. E., & Mandrekar, J. N. (2009) · CHEST Journal · doi:10.1378/chest.09-0915 · Cited by 89
Consequences of Screening in Lung Cancer: Development and Dimensionality of a Questionnaire
Brodersen, J., Thorsen, H., & Kreiner, S. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00697.x · Cited by 76
Self-citationOverstating the Evidence for Lung Cancer Screening
Welch, H. G., Woloshin, S., Schwartz, L. M., Gordis, L., Gøtzsche, P. C., Harris, R., Kramer, B. S., & Ransohoff, D. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2289 · Cited by 75
Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire
Brodersen, J., & Thorsen, H. (2008) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430802542508 · Cited by 63
Self-citationAshraf, H., de Hoop, B., Shaker, S. B., et al. (2010) · European Radiology · doi:10.1007/s00330-010-1749-z · Cited by 52
Self-citation
Cited by
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
The global burden of lung cancer: current status and future trends
Leiter, A., Veluswamy, R. R., & Wisnivesky, J. P. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00798-3 · Cited by 1,477
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,244
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Metadata
- Authors
- Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., Mortensen, J., Rasmussen, J. F., Seersholm, N., Skov, B. G., Thorsen, H., Tønnesen, P., & Pedersen, J. H.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2012-01-27
- Volume
- 67
- Issue
- 4
- Pages
- 296-301
- ISSN
- 0040-6376 (ISSN-L)
- 1468-3296
- OpenAlex
- W2143428001
- Cited by
- 390
- References
- 18
- FWCI
- 37.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.